Skip to main content
. 2019 Oct 21;9:15061. doi: 10.1038/s41598-019-51455-8

Figure 4.

Figure 4

Chemical structures of halogen-containing (X = F, Cl, Br, or I) ligands of LAT1 that were used for the docking studies. 30, 3-iodotyrosine* 31, 3,5-diiodotyrosine (pIC50: 5.10) 32, 2-BAMP (2-Bromo α-methyl phenylalanine)* 33, 4-BAMP (4-Bromo α-methyl phenylalanine)* 34, FAMT (3-Fluoro α-methyl tyrosine) (pIC50: 4.48) 35, fenclonine* 36, (±)-2-endo-amino-bis(2-chloroethyl)-7’-amino benzo bicyclo [2.2.1] heptane-2-exo-carboxylic acid (pIC50: 5.67), 37, (±)-2-amino-(bis-2-chloroethyl)-5-aminoindane-2-carboxylic acid) (pIC50: 5.30). The common core element ‘2-Amino-3-phenylpropanoic acid’ in 3037 is indicated in blue. *Indicates that the bioactivity data was not reported in term of pIC50 values.